World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
33249
World Ranking
10849
National Ranking
5584

Joseph E. Oesterling publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph E. Oesterling sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 269 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joseph E. Oesterling D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph E. Oesterling sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joseph E. Oesterling is affiliated with the University of Michigan-Ann Arbor in the United States. Their research contributions are primarily published in the journal Urology, with a total of 24 publications in this venue.

Recent published papers by Joseph E. Oesterling include:

  • Editorial Board, 2021, Urology
  • Editorial Board, 2021, Urology
  • Editorial Board, 2021, Urology
  • Editorial Board, 2021, Urology
  • Editorial Board, 2020, Urology

These papers focus on editorial perspectives within the field, appearing consistently over recent years.

Frequent co-authors collaborating with Joseph E. Oesterling are:

  • Alan W. Partin
  • Pablo Founding Editor
  • Tomas L. Griebling
  • Brent K. Hollenbeck
  • Edmund Infertility

The continual work with these collaborators suggests active contributions to research projects involving multiple experts in the field.

Best Publications

  • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi- institutional update

    Alan W. Partin;Michael W. Kattan;Eric N. P. Subong;Patrick C. Walsh

  • Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

    Joseph E. Oesterling;Steven J. Jacobsen;Christopher G. Chute;Harry A. Guess

  • Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

    Joseph E. Oesterling

  • The prevalence of Prostatism: A Population-Based Survey of Urinary Symptoms

    C.G. Chute;C.G. Chute;L.A. Panser;L.A. Panser;C.J. Girman;C.J. Girman;J.E. Oesterling;J.E. Oesterling

  • PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING

    Thomas J. Polascik;Joseph E. Oesterling;Alan W. Partin

  • Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

    Horst Zincke;Joseph E. Oesterling;Michael L. Blute;Erik J. Bergstralh

  • Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia

    Alan W. Partin;H. Ballentine Carter;Daniel W. Chan;Jonathan I. Epstein

  • The management of renal angiomyolipoma.

    Joseph E. Oesterling;Elliot K. Fishman;Stanford M. Goldman;Fray F. Marshall

  • Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy

    Joseph E. Oesterling;Daniel W. Chan;Jonathan I. Epstein;Allyn W. Kimball

  • Megestrol acetate for the prevention of hot flashes

    Charles Lawrence Loprinzi;John C. Michalak;Susan K. Quella;Judith R. O'fallon

  • The clinical usefulness of prostate specific antigen: update 1994.

    Alan W. Partin;Joseph E. Oesterling;Joseph E. Oesterling

  • Benign prostatic hyperplasia: Diagnosis and treatment

    J. D. McConnell;M. J. Barry;R. C. Bruskewitz;A. J. Bueschen

  • MOLECULAR FORMS OF PROSTATE-SPECIFIC ANTIGEN AND THE HUMAN KALLIKREIN GENE FAMILY A NEW ERA

    Robert T. McCormack;Robert T. McCormack;T.J. Wang;T.J. Wang;Harry G. Rittenhouse;Harry G. Rittenhouse;Robert L. Wolfert;Robert L. Wolfert

  • Free, complexed and total serum prostate-specific antigen : the establishment of appropriate reference ranges for their concentrations and ratios

    Joseph E. Oesterling;Steven J. Jacobsen;George G. Klee;Kim Petterson

  • Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters

    Frank M. Chybowski;Jeffrey J. Larson Keller;Erik J. Bergstralh;Joseph E. Oesterling

  • Prostatic Intraepithelial Neoplasia is Risk Factor for Adenocarcinoma: Predictive Accuracy in Needle Biopsies

    Deborah Davidson;David G. Bostwick;Junqi Qian;Peter C. Wollan

  • The Use of Prostate-Specific Antigen in Staging Patients With Newly Diagnosed Prostate Cancer

    Joseph E. Oesterling;Sandra K. Martin;Erik J. Bergstralh;Franklin C. Lowe

  • Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate Cancer

    Richard G. Middleton;Ian M. Thompson;Mark S. Austenfeld;William H. Cooner

  • Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

    David L. Bluestein;David G. Bostwick;Erik J. Bergstralh;Joseph E. Oesterling

  • Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.

    Walsh Pc

Frequent Co-Authors

Steven J. Jacobsen
Steven J. Jacobsen Kaiser Permanente
Harry A. Guess
Harry A. Guess University of North Carolina at Chapel Hill
Christopher G. Chute
Christopher G. Chute Johns Hopkins University
Patrick C. Walsh
Patrick C. Walsh Johns Hopkins University
Horst Zincke
Horst Zincke Mayo Clinic
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
George G. Klee
George G. Klee Mayo Clinic
Alan W. Partin
Alan W. Partin Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The pathway to a career in medicine is diverse, with several online degree options that complement traditional medical training. Many students are now exploring specialized fields that offer flexibility and a range of professional opportunities.

For those passionate about pharmaceuticals, pursuing an online pharmacist degree can open doors to roles in clinical and retail pharmacy settings. The advancement of digital healthcare also increases demand for experts in health informatics, where managing and analyzing medical data is key to improving patient care.

If you’re interested in administrative roles, the cost and accessibility of medical billing and coding cost programs make them a popular choice for those looking to enter the healthcare workforce quickly. Additionally, becoming a nurse practitioner is more attainable thanks to the rise of cheap online fnp programs, which provide advanced clinical training at a lower tuition rate.

These online pathways offer affordable, flexible, and accredited options to launch or advance your healthcare career in the USA.

Best Scientists Citing Joseph E. Oesterling

Recently Published Articles